We are live on
!
Find out more
VM
VV Manager Portfolio holdings
AUM
$114M
1-Year Est. Return
59.16%
This Fund
S&P 500
This Quarter
Est. Return
+80.39%
1 Year Est. Return
+59.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$25.5M
(+29%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-16.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allogene Therapeutics
ALLO
|
+$17.8M |
| 2 |
Sutro Biopharma
STRO
|
+$952K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.28% |
Similar funds
MCM
GTP
APG
LM
VPMV
CCM
CCM
BWM
VV Manager's Q2 2020 Portfolio in Review
As of Q2 2020, VV Manager held 4 positions worth $114M, up 29% from $88.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
VV Manager withdrew a net $18.8M in Q2 2020, reducing 2 holdings. Its largest reduction was Allogene Therapeutics, cutting an estimated $17.8M.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 69% a quarter earlier.
- VV Manager's biggest Q2 2020 reduction was Allogene Therapeutics, cutting an estimated $17.8M.
- VV Manager's ten largest holdings make up 100% of its $114M portfolio in Q2 2020.
- VV Manager opened 0 new positions and closed 0 in Q2 2020.
- VV Manager's portfolio value rose 29% quarter-over-quarter to $114M.
Based on VV Manager's 13F filing for Q2 2020, filed 4 Aug 2020.